LONDON, June 5 (Reuters) - Doctors in Europe can continue to use Sanofi-Aventis SA's heparin medicine Lovenox, despite low levels of contamination found in some batches of the product, the European ...
Rockville, MD - The FDA's MedWatch program and Aventis Pharmaceuticals have issued a reminder to physicians about the use of enoxaparin (Lovenox TM) in patients with renal impairment. According to ...
(Reuters) - The U.S. Food and Drug Administration issued a new warning on the use of the anticoagulant Lovenox in patients fitted with a spinal catheter because of the risk of spinal column bleeding ...
Aug. 18, 2004 — The U.S. Food and Drug Administration (FDA) and Aventis Pharmaceuticals notified healthcare professionals in March of revisions to the precautions section of drug labeling for ...
BRIDGEWATER, N.J., Feb. 7 (UPI) -- Sanofi-aventis said Wednesday the U.S. Food and Drug Administration granted its blood-thinner Lovenox priority review for acute heart attack. The company said it is ...
Uninsured people who paid out of pocket for the anticoagulant drug Lovenox may be eligible for a payment from a $120 million proposed settlement in a dispute between Nashville General Hospital and two ...
Well, we sort of figured this was coming. Sanofi-Aventis has gone to court here in Washington to prevent rival drugmaker Novartis from selling a generic version of the blockbuster blood-thinner ...
Yesterday a judge put off a ruling on Sanofi-Aventis's request to keep a generic version of its anti-clotting drug Lovenoxfrom hitting the market, saying he needed more time to review the details of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback